Search
for
Sort by
Research 301–330 of 474
- Alopecia Areata
- Generation of autoreactive CD8 T cell in a mouse model of alopecia areata
- Innate lymphoid cells type 1 may be new, non-antigen-specific player in the pathogenesis of alopecia areata
- Inhibiting Janus kinases to treat alopecia areata
- Janus Kinase Inhibitors against Other Biological Treatments in Alopecia Areata
- Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease‐associated psychological morbidity
- 2‐deoxy D‐glucose treatment does not elicit a hair growth response in alopecia areata
- Butyrophilin-like 2 (BTNL2) to the Rescue: controlling autoaggressive dermal gamma delta (GD) T lymphocytes in human hair follicles (HFs) 3747
- Nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of tofacitinib for treating alopecia areata
- 431 Innate lymphoid cells type 1 may be new, non-antigen-specific player in the pathogenesis of alopecia areata
- Pharmacological Inhibition of Stearoyl CoA Desaturase in the Skin Induces Atrophy of the Sebaceous Glands
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Increase in IL-15 levels in patients with alopecia areata
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata
- Evidence for the off-label use of tofacitinib in alopecia areata
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- New drugs under investigation for the treatment of alopecias
- The Changing Landscape of Alopecia Areata: The Translational Landscape
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- Association between genetically predicted rheumatoid arthritis and alopecia areata: a two-sample Mendelian randomization study
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- New therapies for alopecia areata